Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Frankfurt - Delayed Quote EUR

Inuvo, Inc. (CD5N.F)

0.3325
+0.0140
+(4.40%)
As of 8:04:32 AM GMT+2. Market Open.
Loading Chart for CD5N.F
  • Previous Close 0.3185
  • Open 0.3325
  • Bid 0.3320 x 127700
  • Ask 0.3460 x 122800
  • Day's Range 0.3325 - 0.3325
  • 52 Week Range 0.1734 - 0.8050
  • Volume 1,508
  • Avg. Volume 2,038
  • Market Cap (intraday) 49.641M
  • Beta (5Y Monthly) 0.91
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0300
  • Earnings Date May 5, 2025 - May 9, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Inuvo, Inc., an advertising technology and services company, develops and commercializes large language generative artificial intelligence that discovers and targets digital audiences in the United States. The company offers IntentKey, an artificial intelligence-based consumer intent recognition system designed to reach targeted mobile and desktop in-market audiences, which can serve multiple creative formats including display, video, audio and native across multiple device types including desktop, mobile, tablet, connected/smart TV and game consoles. Its technology also optimizes the purchase and placement of advertising in real time. The company sells its information technology solutions to agencies, brands, and large consolidators of advertising demand. It markets its products through websites, social media platforms, blogs, public relations, trade shows, and conferences. Inuvo, Inc. is headquartered in Little Rock, Arkansas.

inuvo.com

82

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CD5N.F

View More

Performance Overview: CD5N.F

Trailing total returns as of 4/23/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

CD5N.F
34.29%
S&P 500 (^GSPC)
10.10%

1-Year Return

CD5N.F
11.39%
S&P 500 (^GSPC)
4.28%

3-Year Return

CD5N.F
13.14%
S&P 500 (^GSPC)
23.78%

5-Year Return

CD5N.F
93.31%
S&P 500 (^GSPC)
89.00%

Compare To: CD5N.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CD5N.F

View More

Valuation Measures

Annual
As of 4/21/2025
  • Market Cap

    47.65M

  • Enterprise Value

    46.38M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.62

  • Price/Book (mrq)

    3.93

  • Enterprise Value/Revenue

    0.66

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -6.88%

  • Return on Assets (ttm)

    -10.67%

  • Return on Equity (ttm)

    -37.84%

  • Revenue (ttm)

    83.79M

  • Net Income Avi to Common (ttm)

    -5.76M

  • Diluted EPS (ttm)

    -0.0300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.46M

  • Total Debt/Equity (mrq)

    7.54%

  • Levered Free Cash Flow (ttm)

    -784.92k

Research Analysis: CD5N.F

View More

Company Insights: CD5N.F

Research Reports: CD5N.F

View More

People Also Watch